Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approval
Fierce Pharma
FDA approves Denali's Hunter syndrome drug
In approving Avlayah, the FDA has greenlit the first treatment for Hunter syndrome that addresses the condition’s pernicious cognitive symptoms.
Darren Incorvaia
Mar 25, 2026 2:50pm
JenaValve secures FDA's 1st approval in aortic regurgitation
Mar 18, 2026 10:05am
Novocure gets FDA nod for device targeting pancreatic cancer
Feb 17, 2026 4:15am
Guardant Health gets FDA nod to expand test for colon cancer
Jan 26, 2026 8:15am
After 20 years, Medtronic claims neurostim approval in dystonia
Dec 4, 2025 10:25am
Ceribell nets FDA nod for detecting seizures in preterm newborns
Nov 26, 2025 9:49am